The U.S. Preventive Services Task Force (USPSTF) is seeking public comment on its draft recommendation on adult screening for hepatitis C virus (HCV) until Dec. 24, the agency announced.
Phase 3 Trial to Evaluate Molnupiravir for Treatment of COVID-19 in High-Risk Adults
The MOVe-NOW study will assess the investigational oral antiviral using a different formulation than what is currently approved under an emergency use authorization.
American Pharmacies: Powering the Profession Through Leadership
Drug Topics sat down with Laird Leavoy, President of American Pharmacies, to discuss the role leadership plays in the independent pharmacy industry.
Truth or Trend? Equipping Patients to Combat Misinformation
Pharmacists can monitor what health information circulates in mainstream media. But how can they rebut misinformation spread in private channels?
How Centralized Fulfillment is Making Pharmacy More Efficient
Tom Utech, PharmD, CEO of iA, joined Drug Topics to discuss his company’s centralized pharmacy fulfillment solutions.
Post-Surgical Pain Treatment Gains FDA Breakthrough Therapy Designation
ATX101 from Allay Therapeutics is designed for use following total knee arthroplasty in adults and has shown positive results in multiple studies.
Tirzepatide Bests Semaglutide in Relative, Average Weight Loss in Obesity, Overweight
The drugs were compared over a 72-week study period.